Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomed Research International|January 12, 2017
TAMH: A Useful In Vitro Model for Assessing Hepatotoxic MechanismsMadison Davis, Brendan D Stamper
Physiology & Behavior|January 10, 2026
A larger amount of palatable food is needed to provide stress relief during Western diet-induced obesityIvanka Rainer, Leah Hershberger, Megan Pedicini, et al.
Neuroscience|December 1, 2021
The Interactions Between Primary Somatosensory and Motor Cortex during Human Grasping BehaviorsMadison Davis, Yiyu Wang, Shancheng Bao, et al.
AIDS and Behavior|February 3, 2025
Pilot Trial of a Transdiagnostic Cognitive Behavioral Therapy (CBT)-Based Group Intervention to Reduce Psychological Distress, Facilitate Positive Behavior Change, and Mitigate Inflammation in Older People with HIVJacklyn D Foley, Madison Davis, Stephanie Schiavo, et al.
Gene Regulation and Systems Biology|February 23, 2019
Model-based Evaluation of Gene Expression Changes in Response to <i>Leishmania</i> InfectionBrendan D Stamper, Madison Davis, Sean Scott-Collins, et al.
Advances in Mind-Body Medicine|May 31, 2015
Improving access to yoga: barriers to and motivators for practice among health professions studentsChristiane Brems, Lauren Justice, Kari Sulenes, et al.
International Journal of Systematic and Evolutionary Microbiology|March 11, 2022
<i>Thiomicrorhabdus heinhorstiae</i> sp. nov. and <i>Thiomicrorhabdus cannonii</i> sp. nov.: novel sulphur-oxidizing chemolithoautotrophs isolated from the chemocline of Hospital Hole, an anchialine sinkhole in Spring Hill, Florida, USATatum Updegraff, Grayson Schiff-Clark, Hunter Gossett, et al.
Journal of Pharmaceutical Sciences|March 1, 2021
Machine Learning and Accelerated Stress Approaches to Differentiate Potential Causes of Aggregation in Polyclonal Antibody Formulations During ShippingAlyssa E Witeof, Austin L Daniels, Laura T Rea, et al.
The Journal of Clinical Investigation|June 19, 2025
Clinical, tumor, and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphomaSoumya Poddar, Jiali Yan, Gayatri Tiwari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Pageof 2